RLMD vs SLS (Relmada Therapeutics Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Sep, 14 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Today's Session Official Close
The regular trading session has completed and official closing prices are verified as of 9:00 PM ET. All metrics below represent finalized session performance.
RLMD leads by +1.98% Alpha Spread Today
RLMD is trading at -1.77% while SLS is at -3.75% .
Started At
Official opening auction price
Closed At
Official exchange closing price
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | RLMD | SLS | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -1.77% | -3.75% | RLMD +1.98% |
| Net Dollar Move | $-0.08 | $-0.44 | RLMD higher move |
| Open Price | $4.52 | $11.60 | Gap: 0.00% vs -1.11% |
| Day High | $4.56 | $11.70 | Session peaks |
| Day Low | $4.42 | $11.03 | Session troughs |
| Intraday Spread | $0.14 | $0.67 | High/Low spread |
| Share Volume | 1.26M | 5.22M | SLS more active |
| Est. Dollar Volume | $5.61M | $58.91M | SLS higher liquidity |
Explore RLMD vs SLS Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.